Aclaris Therapeutics Clears 2026 Annual Meeting Agenda as Shareholders Back All Proposals
Aclaris Therapeutics (NASDAQ:ACRS) held its 2026 Annual Meeting of Stockholders virtually on Thursday, June 4, with shareholders approving all three proposals presented during the formal portion of the meeting, according to the company’s meeting transcript. Neal Walker, Chief Executive Officer and Chair of the Board of Directors, opened the meeting and said the virtual format […]
4 Jun 20:06 · The Markets Daily